Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Pettus

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Current Medical Research and Opinion|May 25, 2017
Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practiceJennifer Goldman, Christoph Kapitza, Jeremy Pettus, et al.
Diabetes Technology & Therapeutics|June 15, 2018
Recommendations for Initiating Use of Afrezza Inhaled Insulin in Individuals with Type 1 DiabetesJeremy Pettus, Tricia Santos Cavaiola, Steven V Edelman
Primary Care Diabetes|December 1, 2020
Utilizing continuous glucose monitoring in primary care practice: What the numbers meanSteven V Edelman, Tricia Santos Cavaiola, Schafer Boeder, et al.
Diabetes/Metabolism Research and Reviews|October 29, 2015
The past, present, and future of basal insulinsJeremy Pettus, Tricia Santos Cavaiola, William V Tamborlane, et al.
Journal of Diabetes|November 20, 2025
The Role of Incretins in Obstructive Sleep Apnea "GLP1RAs and GLP1RA/GIPRAs in OSA"Ana Lucia Fuentes, Gurleen Dhami, Jeremy Pettus, et al.
Diabetes Care|October 24, 2018
Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose MonitoringSteven V Edelman, Nicholas B Argento, Jeremy Pettus, et al.
Diabetes|September 22, 2019
Single-Cell Analysis of CD4 T Cells in Type 1 Diabetes: From Mouse to Man, How to Perform Mechanistic StudiesSiddhartha Sharma, Jeremy Pettus, Michael Gottschalk, et al.
Diabetes, Obesity & Metabolism|January 19, 2017
Dapagliflozin in patients with type 1 diabetes: A post hoc analysis of the effect of insulin dose adjustments on 24-hour continuously monitored mean glucose and fasting β-hydroxybutyrate levels in a phase IIa pilot studyRobert R Henry, Paresh Dandona, Jeremy Pettus, et al.
Current Medical Research and Opinion|June 4, 2014
Testing versus guessing blood glucose values: impact on self-care behaviors in type 2 diabetesJeremy Pettus, Patricia Stenger, Holly C Schachner, et al.
Diabetes, Obesity & Metabolism|April 18, 2019
Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: A multicentre, randomized controlled trial using continuous glucose monitoringJeremy Pettus, Jasvinder Gill, Sachin Paranjape, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Current Medical Research and Opinion|May 25, 2017
Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practiceJennifer Goldman, Christoph Kapitza, Jeremy Pettus, et al.
Diabetes Technology & Therapeutics|June 15, 2018
Recommendations for Initiating Use of Afrezza Inhaled Insulin in Individuals with Type 1 DiabetesJeremy Pettus, Tricia Santos Cavaiola, Steven V Edelman
Primary Care Diabetes|December 1, 2020
Utilizing continuous glucose monitoring in primary care practice: What the numbers meanSteven V Edelman, Tricia Santos Cavaiola, Schafer Boeder, et al.
Diabetes/Metabolism Research and Reviews|October 29, 2015
The past, present, and future of basal insulinsJeremy Pettus, Tricia Santos Cavaiola, William V Tamborlane, et al.
Journal of Diabetes|November 20, 2025
The Role of Incretins in Obstructive Sleep Apnea "GLP1RAs and GLP1RA/GIPRAs in OSA"Ana Lucia Fuentes, Gurleen Dhami, Jeremy Pettus, et al.
Diabetes Care|October 24, 2018
Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose MonitoringSteven V Edelman, Nicholas B Argento, Jeremy Pettus, et al.
Diabetes|September 22, 2019
Single-Cell Analysis of CD4 T Cells in Type 1 Diabetes: From Mouse to Man, How to Perform Mechanistic StudiesSiddhartha Sharma, Jeremy Pettus, Michael Gottschalk, et al.
Diabetes, Obesity & Metabolism|January 19, 2017
Dapagliflozin in patients with type 1 diabetes: A post hoc analysis of the effect of insulin dose adjustments on 24-hour continuously monitored mean glucose and fasting β-hydroxybutyrate levels in a phase IIa pilot studyRobert R Henry, Paresh Dandona, Jeremy Pettus, et al.
Current Medical Research and Opinion|June 4, 2014
Testing versus guessing blood glucose values: impact on self-care behaviors in type 2 diabetesJeremy Pettus, Patricia Stenger, Holly C Schachner, et al.
Diabetes, Obesity & Metabolism|April 18, 2019
Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: A multicentre, randomized controlled trial using continuous glucose monitoringJeremy Pettus, Jasvinder Gill, Sachin Paranjape, et al.
Pageof 5